“Efficacy and Safety of Ruxolitinib Plus Extracorporeal Photopheresis in Acute and Chronic Graft Versus Host Disease: A Single Center Experience”. Annals of Medical Research 28, no. 11 (November 24, 2021): 2065–2070. Accessed May 9, 2025. http://www.annalsmedres.org/index.php/aomr/article/view/3977.